Biologic

Micronization offers numerous benefits for biological products in the oncology pharmaceutical industry

Micronization of biological products is a crucial process for the pharmaceutical industry, particularly in oncology. Munit has experience in micronizing biologics and adheres to the current guidelines of Good Manufacturing Practices (GMP) to ensure the highest quality and safety standards are met.

Micronization offers numerous benefits for biological products in the oncology pharmaceutical industry:

  • We approach an alternative way for bio-molecule drug delivery
  • Enhanced Bioavailability: Micronized particles have a larger surface area, making them more accessible for the body to absorb and increasing their bioavailability. This results in a more substantial therapeutic effect of the active ingredient.
  • Improved Stability: Smaller particles are less prone to aggregation, which can cause instability in biological products. Micronization helps maintain the product's stability, extending its shelf life and ensuring its quality over time.
  • More substantial Therapeutic Effect: By reducing the particle size of biological products, the rate at which they are absorbed into the bloodstream increases, leading to a stronger therapeutic effect.

The larger surface area of micronized particles makes them more accessible for the body to absorb, resulting in the active ingredient's more potent therapeutic effect. Moreover, smaller particles are less prone to aggregation, which can cause instability in biological products. Micronization helps maintain the stability of the product, extending its shelf life and ensuring its quality over time.

In conclusion, micronization plays a critical role in the development of safe and effective medicines for oncology. Munit's expertise in micronizing biologics by GMP standards ensures the highest level of quality and safety, making it an essential aspect of the pharmaceutical industry. Furthermore, the benefits of micronization, including enhanced bioavailability, improved stability and a stronger therapeutic effect, demonstrate its importance in maximizing the benefits of biological products, as well as small molecules.

Start a project with us

We are world leading player in the field of particle size engineering for pharmaceutical substances.

Our Services

Additional Services in Micronization and Milling
Contact Us

Start a project with us

Find out how Munit can help you to increase the bioavailability of your pharmaceutical substances by reducing their particle size.

Cookie bar

We use cookies and other tracking technologies to improve your experience and analyse our website traffic.

Please consult our Privacy Policy for more information.

By clicking on “Accept”, you consent to your data being collected

You can change your cookie settings and disable cookies, except for essential functional ones, at any time.


Functional
Preference
Statistical
Marketing